Lerato Mmusi-Landela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lerato Mmusi-Landela has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Masilo C. Mathiba
University of Johannesburg
1 shared publication - Solani David Mathebula
Department of Optometry, University of Limpopo, Polokwane 0727, South Africa
1 shared publication - Thokozile Ingrid Metsing
University of Johannesburg
1 shared publication
Latest Publications
- Open Access
- 22 December 2023
- Published by AOSIS in African Vision and Eye Health
- Vol. 83 (1) , 7
Glaucoma knowledge and attitudes among diagnosed participants at a Vhembe clinic, South Africa
Background: Glaucoma remains a major public health concern worldwide. Most patients are dropping out of care, oblivious to the symptomless nature of glaucoma disease. Aim: This study aimed to investigate glaucoma knowledge and attitudes among those diagnosed with the condition in the Limpopo province (South Africa). Setting: The study was conducted at Elim Hospital in the Vhembe District of the Limpopo province, South Africa. Methods: The design of this study was cross-sectional and quantitative in approach. Those diagnosed with glaucoma and receiving eye care treatment at a district hospital in Limpopo province were purposively selected to participate in the study. Quantitative data on knowledge and attitudes towards glaucoma was collected and analysed using a self-administered questionnaire. Results: Eighty-nine purposively selected glaucoma patients, with an average age of 61.20 ± 14.77 years, participated in the study. Participants had an average knowledge score of 43 ± 20.87, with over 50% demonstrating an understanding of the importance of follow-up care, that treatment can slow the condition, and that the condition can progress rapidly if left untreated. The socio-demographic factors found to be statistically significant in relation to glaucoma knowledge were education and the duration of the condition, with p-values of 0.000 and 0.002, respectively. Concerns regarding the condition were expressed by the majority of participants, totalling 82% (n = 73). Conclusion: Awareness programmes need to be implemented to spread knowledge about the nature of glaucoma and the importance of adherence to treatment among those with low levels of education and newly diagnosed patients. Contribution: Awareness and knowledge regarding glaucoma can assist patients in treatment adherence, alleviation of the disease burden and concerns related to the eventuality of becoming blind.
- 22 December 2023
- Published by AOSIS in African Vision and Eye Health
- Vol. 83 (1) , 7
Open AccessGlaucoma knowledge and attitudes among diagnosed participants at a Vhembe clinic, South Africa
Background: Glaucoma remains a major public health concern worldwide. Most patients are dropping out of care, oblivious to the symptomless nature of glaucoma disease. Aim: This study aimed to investigate glaucoma knowledge and attitudes among those diagnosed with the condition in the Limpopo province (South Africa). Setting: The study was conducted at Elim Hospital in the Vhembe District of the Limpopo province, South Africa. Methods: The design of this study was cross-sectional and quantitative in approach. Those diagnosed with glaucoma and receiving eye care treatment at a district hospital in Limpopo province were purposively selected to participate in the study. Quantitative data on knowledge and attitudes towards glaucoma was collected and analysed using a self-administered questionnaire. Results: Eighty-nine purposively selected glaucoma patients, with an average age of 61.20 ± 14.77 years, participated in the study. Participants had an average knowledge score of 43 ± 20.87, with over 50% demonstrating an understanding of the importance of follow-up care, that treatment can slow the condition, and that the condition can progress rapidly if left untreated. The socio-demographic factors found to be statistically significant in relation to glaucoma knowledge were education and the duration of the condition, with p-values of 0.000 and 0.002, respectively. Concerns regarding the condition were expressed by the majority of participants, totalling 82% (n = 73). Conclusion: Awareness programmes need to be implemented to spread knowledge about the nature of glaucoma and the importance of adherence to treatment among those with low levels of education and newly diagnosed patients. Contribution: Awareness and knowledge regarding glaucoma can assist patients in treatment adherence, alleviation of the disease burden and concerns related to the eventuality of becoming blind.
- Open Access
- 22 December 2023
- Published by AOSIS in African Vision and Eye Health
- Vol. 83 (1)
Pathophysiology of dry eye disease and novel therapeutic agents
Background: Dry eye disease (DED) is one of the most common ocular surface diseases, which is caused by decreased tear production or increased evaporation. It is a growing public health concern as it influences the quality of life and work and visual function. Aim: This review will update health care professionals about some of the latest research concerning DED and its treatment. Method: An extensive literature search was conducted on studies that investigated the aetiology, pathophysiology and treatment options of DED. Results: The search returned 51 articles that were included in this review. All reviewed papers showed that DED is characterised by the loss of homeostasis, resulting in tear film instability, hyperosmolarity and inflammation of the ocular surface. Conclusion: The causes of DED are complicated and multifactorial but currently, inflammation of the ocular surface is believed to be the main cause. The many different potential topical and systemic treatments have evolved to provide a targeted and effective treatment option from which clinicians can choose. Most of the potential new drugs have been designed to control inflammation and restore the usual or normal quantity of tears. Contribution: The goal of treatment should be to improve the patient’s symptoms and/or may be even the signs if present, and a good relationship between the patient and doctor is crucial for the management plan.
- 22 December 2023
- Published by AOSIS in African Vision and Eye Health
- Vol. 83 (1)
Open AccessPathophysiology of dry eye disease and novel therapeutic agents
Background: Dry eye disease (DED) is one of the most common ocular surface diseases, which is caused by decreased tear production or increased evaporation. It is a growing public health concern as it influences the quality of life and work and visual function. Aim: This review will update health care professionals about some of the latest research concerning DED and its treatment. Method: An extensive literature search was conducted on studies that investigated the aetiology, pathophysiology and treatment options of DED. Results: The search returned 51 articles that were included in this review. All reviewed papers showed that DED is characterised by the loss of homeostasis, resulting in tear film instability, hyperosmolarity and inflammation of the ocular surface. Conclusion: The causes of DED are complicated and multifactorial but currently, inflammation of the ocular surface is believed to be the main cause. The many different potential topical and systemic treatments have evolved to provide a targeted and effective treatment option from which clinicians can choose. Most of the potential new drugs have been designed to control inflammation and restore the usual or normal quantity of tears. Contribution: The goal of treatment should be to improve the patient’s symptoms and/or may be even the signs if present, and a good relationship between the patient and doctor is crucial for the management plan.